Difference between revisions of "Case for Public Funding and Public Oversight of Clinical Trials"

From P2P Foundation
Jump to navigation Jump to search
(Created page with ' '''Article: Lewis, Tracy R.; Reichman, Jerome H.; and So, Anthony D. (2007) "The Case for Public Funding and Public Oversight of Clinical Trials," The Economists' Voice: Vol. 4 ...')
 
 
Line 1: Line 1:
 
 
'''Article: Lewis, Tracy R.; Reichman, Jerome H.; and So, Anthony D. (2007) "The Case for Public Funding and Public Oversight of Clinical Trials," The Economists' Voice: Vol. 4 : Iss. 1, Article 3.'''
 
'''Article: Lewis, Tracy R.; Reichman, Jerome H.; and So, Anthony D. (2007) "The Case for Public Funding and Public Oversight of Clinical Trials," The Economists' Voice: Vol. 4 : Iss. 1, Article 3.'''
  
Line 13: Line 12:
  
 
[[Category:Policy]]
 
[[Category:Policy]]
 +
 +
 +
[[Category:Peerfunding]]

Latest revision as of 05:45, 16 June 2010

Article: Lewis, Tracy R.; Reichman, Jerome H.; and So, Anthony D. (2007) "The Case for Public Funding and Public Oversight of Clinical Trials," The Economists' Voice: Vol. 4 : Iss. 1, Article 3.


URL = http://www.bepress.com/ev/vol4/iss1/art3

Clinical drug trials are public goods and should be publicly funded to avoid undersupply, the suppression of adverse results and other problems, according to Tracy R. Lewis, Jerome H. Reichman and Anthony D. So.